SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Neovasc, Inc. And Advises Investors to Contact the Firm

IRVINE, Calif.--()--Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Neovasc, Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased shares of Neovasc during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on multiple media reports that claim a Massachusetts federal jury awarded a $70 million verdict to Neovasc's rival, CardiAQ Valve Technologies Inc. ("CardiAQ"), finding that Neovasc had stolen trade secrets from CardiAQ.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

Contacts

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com